Document Detail


Monotherapy with pefloxacin in multidrug-resistant nosocomial gram-negative bacteraemia.
MedLine Citation:
PMID:  2258357     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Twenty patients who developed nosocomial Gram-negative bacteraemias in the medical or surgical intensive care units were treated with pefloxacin. All organisms were susceptible to pefloxacin and had not responded to previous antimicrobial therapy. The bacteraemias were eradicated in 16 of the 20 patients, all of whom tolerated the therapy without adverse effects.
Authors:
B M Limson; A C Peña; M D Garvez
Related Documents :
2520127 - Postoperative management of the neurosurgical patient.
8055207 - Fatal cholestatic hepatitis caused by d-penicillamine.
8845537 - Acute respiratory distress syndrome.
17071307 - Transcutaneous electrical stimulation versus traditional dysphagia therapy: a nonconcur...
17149717 - High incidence of vascular reconstructions in socioeconomically deprived areas of an ur...
7874667 - The cost of schizophrenia.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  The Journal of antimicrobial chemotherapy     Volume:  26 Suppl B     ISSN:  0305-7453     ISO Abbreviation:  J. Antimicrob. Chemother.     Publication Date:  1990 Oct 
Date Detail:
Created Date:  1991-01-29     Completed Date:  1991-01-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7513617     Medline TA:  J Antimicrob Chemother     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  91-5     Citation Subset:  IM    
Affiliation:
Makati Medical Center, Manila, Philippines.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adult
Aged
Cross Infection / drug therapy*
Drug Resistance, Microbial
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Pefloxacin / administration & dosage,  therapeutic use*
Pneumonia / complications
Pseudomonas Infections / complications,  drug therapy
Sepsis / complications,  drug therapy*
Chemical
Reg. No./Substance:
70458-92-3/Pefloxacin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pefloxacin therapy for nosocomial infections in the intensive care unit.
Next Document:  Pefloxacin in the treatment of septicaemia: three years' experience.